Slide Insurance Holdings (NYSE:SLDE) President and Chief Operating Officer Lucas Shannon executed a series of stock sales under a prearranged 10b5-1 trading plan, disposing of a total of 36,791 common shares from April 6 through April 8, 2026. The gross proceeds from these transactions amounted to roughly $663,573.
The sales were carried out at prices spanning $18.00 to $18.09 per share. On April 6, 2026 Shannon sold 13,500 shares at a weighted average price of $18.09. The next day, April 7, he sold 11,283 shares at a weighted average price of $18.00. The final tranche occurred on April 8, 2026, when 12,008 shares were sold at a weighted average price of $18.01. As of the time of reporting, Slide Insurance stock trades at $18.11, a price close to the levels at which the shares were sold.
Following the completion of these sales, Shannon's indirect holding through Securus Risk Management, LLC was reduced to 1,454,138 shares. Separately, Shannon holds 208,101 shares directly. He also disclaims beneficial ownership of a number of significant positions held by others, including 1,137,546 shares held by his spouse, 37,894,635 shares held through IIM Holdings II, LLC, 1,925,000 shares held through the Emma Cloonen Irrevocable Trust, 1,925,000 shares in the Ava Cloonen Irrevocable Trust, and 2,575,837 shares held through the Bruce Lucas Irrevocable Grantor Retained Annuity Trust of 2014.
InvestingPro analysis referenced in company materials indicates Slide Insurance appears undervalued on a Fair Value basis, with analyst price targets ranging from $23 to $29. The company is also described as having a "GREAT" financial health score and carrying a market capitalization of $2.23 billion.
Recent operating and market developments
Slide Insurance reported strong fourth-quarter 2025 results that materially exceeded analyst expectations. The company recorded earnings per share of $1.23 for the quarter, compared with the consensus forecast of $0.71, marking a 73.24% surprise. Quarterly revenue reached $347 million, up from $238.5 million in the year-ago period.
In addition to the quarterly performance, Slide Insurance completed a previously announced $120 million stock repurchase program and approved a new $125 million buyback authorization.
Those results and capital actions have been met with positive responses from several research firms. Keefe, Bruyette & Woods raised their price target on the stock to $23, citing the company’s strong fourth-quarter results and favorable loss trends. Barclays reiterated an Overweight rating with a price target of $29. Texas Capital Securities initiated coverage with a Buy rating and a $25 price target. These analyst actions establish a range of targets between $23 and $29.
Context and market signals
The insider sale was executed through a 10b5-1 plan, which indicates the trades were prearranged. The timing coincides with a period in which the company has demonstrated strong operating performance and expanded shareholder return programs. The stock’s trading price at $18.11 sits below the analyst target band referenced above.
Observers tracking corporate insiders and equity markets will note both the reduction in indirect ownership by Shannon and the company’s recent financial and capital allocation signals. The facts presented here reflect disclosed transactions, filings, and published analyst assessments.